Curran Daniel J.
Insider CIK 1887599 · CPRX Director · ALXO Director · XLO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 40,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 5,468 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 18,115 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2026-01-20 | 2026-01-21 | 16,833 | — | $0 | 16,833 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 5,468 | — | $0 | 63,583 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 18,115 | — | $0 | 58,115 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2025-08-12 | 2025-08-13 | 40,400 | — | $0 | 40,400 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 31,000 | — | $0 | 31,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2024-06-14 | 2024-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |